Cargando…
Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients
BACKGROUND: Several studies have identified L1 cell adhesion molecule (L1CAM) as a strong prognostic marker in endometrial cancer. To further underline the clinical usefulness of this biomarker, we investigated L1CAM as a predictive marker for lymph node metastases and its prognostic impact in curet...
Autores principales: | Tangen, Ingvild L, Kopperud, Reidun K, Visser, Nicole CM, Staff, Anne C, Tingulstad, Solveig, Marcickiewicz, Janusz, Amant, Frédéric, Bjørge, Line, Pijnenborg, Johanna MA, Salvesen, Helga B, Werner, Henrica MJ, Trovik, Jone, Krakstad, Camilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589986/ https://www.ncbi.nlm.nih.gov/pubmed/28751757 http://dx.doi.org/10.1038/bjc.2017.235 |
Ejemplares similares
-
Late-week surgical treatment of endometrial cancer is associated with worse long-term outcome: Results from a prospective, multicenter study
por: Njølstad, Tormund S., et al.
Publicado: (2017) -
L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
por: van der Putten, Louis JM, et al.
Publicado: (2016) -
Androgen receptor as potential therapeutic target in metastatic endometrial cancer
por: Tangen, Ingvild Løberg, et al.
Publicado: (2016) -
DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer
por: Njølstad, T S, et al.
Publicado: (2015) -
Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer
por: Werner, Henrica M. J., et al.
Publicado: (2014)